Welcome : Guest

Horizon Pharma Plc (Ireland) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Horizon Pharma Plc, which is principally involved in Biopharmaceuticals Business. Illustrated with 17 tables, the report showcases the company's sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-64581
Price: $850
Company Type: Public
Pages: 20
Date: November 2016
Market Data Tables: 17

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Horizon Pharma Plc’s Sales by Product Category Worldwide (2015) in Percentage for Medicines (Duexis, Vimovo, Pennsaid 2%, Actimmune, Ravicti, Rayos, Buphenyl, and Lodotra)......3
Table 2: Horizon Pharma Plc’s Sales by Geographic Region Worldwide (2014-2015) in Percentage for United States, and Rest of World......4
Table 3: Horizon Pharma Plc's Sales by Product Segment (2014) in Percentage for Vimovo, Duexis, Actimmune, Rayos and Lodotra......5
Specialty Pharma & Orphan Drugs......7
Table 4: Specialty Pharma & Orphan Drug Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, US and Rest of the World......7
Rheumatology Drugs......8
Table 5: Rheumatology Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Biologicals, Coxibs, NSAIDs, TNF Inhibitors, and Others......8
Table 6: Rheumatology Drugs Market by Product Type in the US (2015) - Percentage Share Breakdown by Value Sales for Biologicals/TNF Inhibitors, Coxibs, DMARDS, Gout, MuscleRelaxants, NSAIDS, and Others......9
Patient Care......10
Table 7: Patient Care Physician Market for Age Group (0-17 Years) by Specialty in the US (2015) - Percentage Share Breakdown by No. of Patients for Medical Specialties, Primary Care, Surgery, and Other Care......10
Table 8: Patient Care Physician Market for Age Group (18-24 Years) by Specialty in the US (2015) - Percentage Share Breakdown by No. of Patients for Medical Specialties, Primary Care, Surgery, and Other Care......11
Table 9: Patient Care Physician Market for Age Group (25-44 Years) by Specialty in the US (2015) - Percentage Share Breakdown by No. of Patients for Medical Specialties, Primary Care, Surgery, and Other Care......12
Table 10: Patient Care Physician Market for Age Group (45-64 Years) by Specialty in the US (2015) - Percentage Share Breakdown by No. of Patients for Medical Specialties, Primary Care, Surgery, and Other Care......13
Table 11: Patient Care Physician Market for Age Group (65-74 Years) by Specialty in the US (2015) - Percentage Share Breakdown by No. of Patients for Medical Specialties, Primary Care, Surgery, and Other Care......14
Table 12: Patient Care Physician Market for Age Group (75+ Years) by Specialty in the US (2015) - Percentage Share Breakdown by No. of Patients for Medical Specialties, Primary Care, Surgery, and Other Care......15
Table 13: Physician Market for Patient Care by Type in the US (2015) - Percentage Share Breakdown by No. of Patients for Non-Primary Care and Primary Care......16
Primary Care......17
Table 14: Physicians for Primary Care Market by Specialty in the US (2015) - Percentage Share Breakdown by No. of Patients for General Family Practice, General Internal Medicine, and Pediatrics......17
Orphan Disease Therapeutics......18
Table 15: Market Shares of Leading Orphan Disease Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Pfizer, Inc., Sanofi S.A., and Others......18
Rheumatology Therapeutics......19
Table 16: Market Shares of Leading Rheumatology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Amgen, Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......19
Table 17: Horizon Pharma Plc’s Sales by Product (2015) - Percentage Share Breakdown by Value for Actimmune, Duexis, Pennsaid 2%, Ravicti, Vimovo, and Others......20